Your browser doesn't support javascript.
loading
Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line.
Weiner, F; Schille, J T; Koczan, D; Wu, X-F; Beller, M; Junghanss, C; Hewicker-Trautwein, M; Murua Escobar, H; Nolte, I.
Afiliação
  • Weiner F; Small Animal Clinic, University of Veterinary Medicine Hannover, 30559, Hannover, Germany.
  • Schille JT; Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, 18057, Rostock, Germany.
  • Koczan D; Small Animal Clinic, University of Veterinary Medicine Hannover, 30559, Hannover, Germany.
  • Wu XF; Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, 18057, Rostock, Germany.
  • Beller M; Core Facility for Microarray Analysis, Institute for Immunology, University of Rostock, 18057, Rostock, Germany.
  • Junghanss C; Leibniz Institute for Catalysis, 18059, Rostock, Germany.
  • Hewicker-Trautwein M; Leibniz Institute for Catalysis, 18059, Rostock, Germany.
  • Murua Escobar H; Department of Medicine, Clinic III, Hematology, Oncology, Palliative Medicine, University of Rostock, 18057, Rostock, Germany.
  • Nolte I; Department of Pathology, University of Veterinary Medicine Hannover, 30559, Hannover, Germany.
BMC Cancer ; 21(1): 1088, 2021 Oct 08.
Article em En | MEDLINE | ID: mdl-34625047
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article